Botulinum toxin type A (botox) for treatment of migraine headaches (Otolaryngol Head Neck Surg.— 2000. Dec. —123(6).—669—676: Англ.)

Cover Page

Cite item

Full Text

Abstract

The aim of the clinical experiment was to evaluate the correlation between the administration of pericranial botulinum toxin type A (botox) and the relief of migraine symptoms.

About the authors

W. Binder

University of California; Columbia University; University of California at San Francisco; University of Southern California

Email: info@eco-vector.com

Mt Sinai Medical Center, College of Physicians and Surgeons

United States, California; Columbia; San Francisco; Southern California

M. Brin

University of California; Columbia University; University of California at San Francisco; University of Southern California

Email: info@eco-vector.com

Mt Sinai Medical Center, College of Physicians and Surgeons

United States, California; Columbia; San Francisco; Southern California

A. Blitzer

University of California; Columbia University; University of California at San Francisco; University of Southern California

Email: info@eco-vector.com

Mt Sinai Medical Center, College of Physicians and Surgeons

United States, California; Columbia; San Francisco; Southern California

L. Schoenrock

University of California; Columbia University; University of California at San Francisco; University of Southern California

Email: info@eco-vector.com

Mt Sinai Medical Center, College of Physicians and Surgeons

United States, California; Columbia; San Francisco; Southern California

J. Pogoda

University of California; Columbia University; University of California at San Francisco; University of Southern California

Author for correspondence.
Email: info@eco-vector.com

Mt Sinai Medical Center, College of Physicians and Surgeons

United States, California; Columbia; San Francisco; Southern California

References


Copyright (c) 2001 Binder W., Brin M., Blitzer A., Schoenrock L., Pogoda J.

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies